Loading organizations...
§ Private Profile · 480 Pleasant Street Watertown, Massachusetts 02472 United States
On-demand market research for healthcare & life sciences. Collects real-time data from medical professionals for drug development & launch.
InCrowd has raised $3.0M across 2 funding rounds.
Key people at InCrowd.
InCrowd has raised $3.0M in total across 2 funding rounds.
InCrowd, based in Boston, Massachusetts, United States, specializes in on-demand market research for the healthcare and life sciences sectors, collecting real-time data from medical professionals to provide rapid market insights for drug development and launch. The company delivers targeted data to support strategic decisions within the life science industry. While specific scale metrics or funding figures are not publicly available, InCrowd has undergone significant corporate transitions, including its acquisition by Apollo Intelligence, which later sold to Frazier Healthcare Partners. More recently, InCrowd was acquired by Saroras in August. Co-founder Diane Hayes, who also served as President, was involved with Apollo Intelligence's board during its ownership. InCrowd was founded in 2011 by co-founder Diane Hayes. The firm focuses on healthcare and life sciences, customers include life science companies.
InCrowd has raised $3.0M across 2 funding rounds. Most recently, it raised $950K Pre-Seed in July 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 17, 2024 | $950K Pre Seed | — | — | Announced |
| Sep 1, 2012 | $2M Series A | Dominic Endicott | B Capital Group, Bessemer Venture Partners, Costanoa Ventures, CRV, Friále, Hannah Grey, Streamlined Ventures, Thirty Five Ventures, Y Combinator, Frederic Kerrest, Mike Slade, Nick Hanauer | Announced |
Key people at InCrowd.
InCrowd has raised $3.0M in total across 2 funding rounds.
InCrowd's investors include Dominic Endicott, B Capital Group, Bessemer Venture Partners, Costanoa Ventures, CRV, Friále, Hannah Grey, Streamlined Ventures, Thirty Five Ventures, Y Combinator, Frederic Kerrest, Mike Slade.
InCrowd, Inc. is a healthcare market research company founded in 2010, specializing in real-time data and insights for the life sciences industry through a cloud-based platform and a proprietary network of healthcare professionals.[1][4][5] Headquartered in Watertown, MA, it served over 100 life sciences firms, including 300+ brands and 18 of the top 20 pharmaceutical companies, by enabling agile micro-research that delivers results in hours via mobile responses from screened professionals.[1][5] The company solved the problem of slow, costly traditional market research by providing immediate, high-quality insights, but was acquired by SARORAS Private Capital in 2019 and later integrated into Konovo, an AI-enabled platform combining InCrowd with other research firms.[1][2]
InCrowd was founded in 2010 by entrepreneurs Janet Kosloff (CEO) and Diane Hayes (President) in Watertown, MA.[1][4] The duo pioneered real-time market research in life sciences, leveraging a sophisticated cloud platform and a global "Crowd" of healthcare professionals to disrupt traditional methods that took weeks.[1][5] Early traction came from awards and adoption by top pharma firms, culminating in the 2019 acquisition by SARORAS Private Capital, advised by Bowen Advisors, which positioned it for growth under new ownership.[1] By the early 2020s, InCrowd integrated into Konovo (formerly Apollo Intelligence), enhancing its AI capabilities alongside Survey Healthcare Global and GlocalMind.[2]
(Note: A separate entity, InCrowd Capital, operates as an angel network for SexTech and cannabis ventures, but lacks overlap with the primary healthcare-focused InCrowd.[3][6])
InCrowd rode the trend of real-time data analytics in healthcare, accelerating insights amid rising demand for agile decision-making in life sciences R&D and market strategies.[1][5] Its timing aligned with pharma's shift to digital tools for faster go-to-market, countering traditional research delays amid regulatory pressures and competitive innovation races.[5] Market forces like mobile adoption (70% responses) and cloud scalability favored its model, influencing the ecosystem by setting standards for on-demand research now amplified in Konovo's AI platform tackling fragmentation.[2][5]
Post-integration into Konovo, InCrowd's legacy powers AI-driven research streamlining, with expansion into global insights ecosystems likely.[2] Trends like AI-native platforms and deeper healthcare data integration will shape its path, evolving influence from pioneer to core component in unified research tech.[2] As life sciences demand instantaneous, quality data intensifies, Konovo—inheriting InCrowd's real-time edge—stands poised to dominate efficient insights delivery.[1][2]
